NOX
NOXOPHARM LIMITED
$0.0550
▼ -6.78%
Market cap
$17M
Turnover
$9,413
Last price
$0.0550
Day change
-6.78%
Announcements
16
Range, past year
Open 0.098 · Low 0.043 · Now 0.055 · High 0.135
Open NOX in the full dashboard →
Charts, screener, momentum and signals across every ASX-listed code.
NOX momentum and trend analysis
Our analysis
Independent analysis generated by Stock Trade Intelligence
as at 2026-10-13.
Momentum quality
29/100
Wyckoff phase
Accumulation7d
Trend stage
Neutral
1 Day
-6.8%
1 Week
-11.3%
1 Month
-26.7%
1 Year
-47.6%
RSI
31
Avg daily range
6.0%
NOXOPHARM LIMITED scores 29 out of 100 for momentum quality, a reading rated very low confidence. The score weighs trend structure, price consistency, volume backing and how long the move has held, so a high reading means a sustained trend rather than a single large day. Its trend is currently classified as Neutral.
On the Wyckoff cycle it sits in Accumulation, where it has been for 7 trading days. The weekly timeframe reads Downtrend, which does not yet agree with the daily view.
Against the wider market it is currently underperforming and the institutional accumulation signal reads low.
Points to watch
- 60d drawdown -45.0%
- Thin liquidity
- Risk rating: Very High
- Composite downside risk elevated
NOX announcements
Recent price-sensitive releases.
- 2026-09-01 Novel oligonucleotides data presented at Options Conference Progress Report
- 2026-08-28 Appendix 4E - Preliminary Financial Report Preliminary Final Report
- 2026-08-26 New preclinical data supports immuno-oncology approach Progress Report
- 2026-07-22 Quarterly Activities/Appendix 4C Cash Flow Report
- 2026-06-09 SOF-SKN manufacturing begins to ensure clinical trial readi
- 2026-05-26 New data confirms cancer-fighting potential
- 2026-05-20 Noxopharms Sofra assets to be presented at global conference
More Health Care stocks
Most traded in the same sector.